Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	11c-acetate	Acetate	-	-	-	3件: 13, 86, 88 💬
2	20mg/0.5ml glatiramer acetate	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
3	40 mg glatiramer acetate	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	2件:  2 , 13 💬
4	40 mg glatiramer acetato	Glatiramer	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
5	5% lidocaine/5 mg/ml 0.02% estradiol compound cream	Estradiol	11件: D00105, D00358, D01413, D01617, D01953, D02086, D04061, D04063, D04064, D04065, D08127 💬	7件: ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	12件: Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway	1件: 226 💬
6	90 mg hydrocortisone acetate suppository with sephure suppository applicator	Acetate	2件: D00088, D00165 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
7	[n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate	Acetate	1件: D02691 💬	1件: GHR 💬	5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	1件: 265 💬
8	Abiraterone	Abiraterone	1件: D09701 💬	-	-	2件: 75, 81 💬
9	Abiraterone acetate	Abiraterone	1件: D09701 💬	-	-	2件: 75, 81 💬
10	Acetate	Acetate	-	-	-	43件:  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
11	Administration of rituximab and methylprednisolone	Methylprednisolone	7件: D00407, D00751, D00979, D02994, D05000, D05001, D05002 💬	2件: MS4A1, NR3C1 💬	2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction	1件: 51 💬
12	Azd4017 and prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 75 💬
13	Bazedoxifene	Bazedoxifene	1件: D03062 💬	-	-	1件: 13 💬
14	Bazedoxifene acetate	Acetate	1件: D03062 💬	-	-	1件: 13 💬
15	Betamethasone	Betamethasone	7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	6件:  2 , 28, 46, 90, 96, 235 💬
16	Betamethasone acibutate	Betamethasone	7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
17	Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days	Acetate	7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件:  2  💬
18	Bortezomib/dexamethasone	Bortezomib	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬	2件: NR3C1, PSMB5 💬	9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 283 💬
19	Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone	Bortezomib	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬	2件: NR3C1, PSMB5 💬	9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 28 💬
20	Bupivacaine/epinephrine/dexamethasone	Bupivacaine	14件: D00095, D00292, D00975, D00996, D01450, D01510, D01615, D01632, D01948, D02149, D02174, D02591, D02592, D07552 💬	15件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 96 💬
21	Caspofungin	Caspofungin	2件: D02501, D07626 💬	-	-	1件: 60 💬
22	Caspofungin acetate	Acetate	2件: D02501, D07626 💬	-	-	1件: 60 💬
23	Cetrorelix	Cetrorelix	2件: D01685, D07665 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 46 💬
24	Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine	Azathioprine	12件: D00238, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994, D03033 💬	2件: MS4A1, NR3C1 💬	2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction	1件: 35 💬
25	Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator	Acetate	2件: D00088, D00165 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
26	Combination therapy with vigabatrin and prednisolone	Prednisolone	9件: D00472, D00535, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	2件: ABAT, NR3C1 💬	8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	1件: 145 💬
27	Control intervention (no dexamethasone)	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
28	Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)	Acetate	21件: D00088, D00292, D00472, D00473, D00973, D00975, D00980, D00981, D00982, D01239, D01510, D01615, D01632, D01948, D01998, D02156, D02174, D02591, D02592, D03301, D07749 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
29	Corticosteroid (prednisolone)	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 85 💬
30	Corticosteroid treatment (methylprednisolone or prednisolone)	Methylprednisolone	14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 64 💬
31	Corticosteroids (prednisone or prednisolone)	Prednisolone	9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 49 💬
32	Cortisone acetate	Acetate	2件: D00973, D07749 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
33	Cosyntropin acetate	Acetate	1件: D00284 💬	1件: MC2R 💬	5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway	1件: 113 💬
34	Cyclophosphamide, azathioprine,prednisone,methylprednisolone	Azathioprine	11件: D00238, D00287, D00407, D00473, D00751, D00979, D03033, D05000, D05001, D05002, D07760 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 42, 43, 45 💬
35	Cyclophosphamide, bortezomib, and dexamethasone (cybord)	Bortezomib	12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬	2件: NR3C1, PSMB5 💬	9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 28 💬
36	Cyclophosphamide, bortezomib, dexamethasone	Bortezomib	12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬	2件: NR3C1, PSMB5 💬	9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	1件: 28 💬
37	Cyclophosphamide, bortezomib, dexamethasone plus daratumumab	Bortezomib	13件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760, D10777 💬	3件: CD38, NR3C1, PSMB5 💬	16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia	1件: 28 💬
38	Cyclophosphamide/glatiramer acetate	Acetate	3件: D00287, D04318, D07760 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
39	Ddavp (desmopressin)	Desmopressin	2件: D00291, D02235 💬	2件: AVPR2, F8 💬	4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 288 💬
40	Delmitide acetate	Acetate	-	-	-	1件: 97 💬
41	Depot leuprolide acetate 3.75 mg	Acetate	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 51 💬
42	Desmopressin	Desmopressin	2件: D00291, D02235 💬	2件: AVPR2, F8 💬	4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	5件:  6 , 64, 72, 225, 288 💬
43	Desmopressin acetat	Desmopressin	2件: D00291, D02235 💬	2件: AVPR2, F8 💬	4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件:  6  💬
44	Desmopressin acetate	Acetate	2件: D00291, D02235 💬	2件: AVPR2, F8 💬	4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	2件: 64, 288 💬
45	Desmopressin acetate trihydrate	Acetate	2件: D00291, D02235 💬	2件: AVPR2, F8 💬	4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 225 💬
46	Desmopressin intranasal	Desmopressin	2件: D00291, D02235 💬	2件: AVPR2, F8 💬	4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 72 💬
47	Desmopressin oral melt	Desmopressin	2件: D00291, D02235 💬	2件: AVPR2, F8 💬	4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 72 💬
48	Device: cellulose acetate with petrolatum	Acetate	3件: D00093, D05304, D05331 💬	-	-	2件: 35, 162 💬
49	Device: dexamethasone injection	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 90 💬
50	Dexamethasone	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
51	Dexamethasone (1 cycle)	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 63 💬
52	Dexamethasone (4 cycles)	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 63 💬
53	Dexamethasone (50mg 1dd6, 3 consecutive days/month)	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 35 💬
54	Dexamethasone 0,1 mg tablets	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
55	Dexamethasone 0,5mg	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 84 💬
56	Dexamethasone 0.5mg tablet	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
57	Dexamethasone 0.5mg/5ml solution	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 35, 162 💬
58	Dexamethasone 0.5mg/5ml solution in mucolox™	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 35, 162 💬
59	Dexamethasone 1,5 mg tablets	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
60	Dexamethasone 21-dihydrogen phosphate	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 65 💬
61	Dexamethasone 21-phosphate	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
62	Dexamethasone 2mg tablets	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
63	Dexamethasone 4 mg jenapharm	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 28 💬
64	Dexamethasone abcur	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 63 💬
65	Dexamethasone and rituximab	Dexamethasone	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994 💬	2件: MS4A1, NR3C1 💬	2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction	1件: 63 💬
66	Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland).	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 235 💬
67	Dexamethasone parotid irrigation	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 53 💬
68	Dexamethasone sodium phosphate	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 65, 70, 96 💬
69	Dexamethasone sodium phosphate 250 mg/ 10 ml	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 96 💬
70	Dexamethasone sodium phosphate 250 mg/10 ml solution	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 299 💬
71	Dexamethasone sodium phosphate ph. eur.	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 65 💬
72	Dexamethasone sodium sulfate	Dexamethasone	11件: D00292, D00975, D01510, D01615, D01632, D01732, D01948, D02174, D02591, D02592, D05877 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 28 💬
73	Dexamethasone soduim phosphate	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 13 💬
74	Dexamethasone, 40 mg	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 28 💬
75	Diagnostic test: dexamethasone test	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 75 💬
76	Dirucotide acetate	Acetate	1件: D09396 💬	-	-	1件: 13 💬
77	Edratide acetate	Acetate	1件: D03957 💬	-	-	1件: 49 💬
78	Estradiol	Estradiol	8件: D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬	2件: ESR1, ESR2 💬	9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	5件: 13, 46, 49, 226, 299 💬
79	Estradiol 2 mg	Estradiol	8件: D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬	2件: ESR1, ESR2 💬	9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	1件: 299 💬
80	Estradiol hemihydrate	Estradiol	8件: D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬	2件: ESR1, ESR2 💬	9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	1件: 13 💬
81	Etanercept, methotrexate, prednisolone	Etanercept	11件: D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬	5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬	70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 56 💬
82	Ethinyl estradiol	Estradiol	9件: D00105, D00554, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬	2件: ESR1, ESR2 💬	9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	3件: 46, 49, 299 💬
83	Experimental glatiramer acetate	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
84	Flecainide	Flecainide	2件: D00638, D07962 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	1件:  6  💬
85	Flecainide acetate	Acetate	2件: D00638, D07962 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	1件:  6  💬
86	Fludrocortisone	Fludrocortisone	2件: D00986, D07967 💬	1件: NR3C2 💬	1件: Aldosterone-regulated sodium reabsorption	3件:  6 , 17, 81 💬
87	Gallium-68-dota-n-octreotide	Octreotide	2件: D00442, D06495 💬	1件: SSTR2 💬	4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway	1件: 84 💬
88	Glatiramer	Glatiramer	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	4件:  2 , 13, 96, 156 💬
89	Glatiramer acetate	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	3件: 13, 96, 156 💬
90	Glatiramer acetate (copaxone®)	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	2件: 13, 156 💬
91	Glatiramer acetate (db)	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
92	Glatiramer acetate (ga)	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
93	Glatiramer acetate (ga) 40 mg	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
94	Glatiramer acetate (gtr)	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
95	Glatiramer acetate (ol)	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
96	Glatiramer acetate 150mg enteric coated tablets	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
97	Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
98	Glatiramer acetate 20 mg	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
99	Glatiramer acetate 20 mg, with mitoxantrone	Acetate	3件: D02166, D04318, D08224 💬	22件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, TOP2A, TOP2B 💬	33件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Platinum drug resistance, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
100	Glatiramer acetate 20 mg/0.5 ml	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
101	Glatiramer acetate 40 mg	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
102	Glatiramer acetate [ga]	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
103	Glatiramer acetate injection with oral cetirizine hydrochloride	Acetate	3件: D00664, D04318, D07662 💬	21件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, HRH1 💬	35件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
104	Glatiramer acetate with minocycline	Acetate	3件: D00850, D04318, D05045 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
105	Glatiramer acetate, (copaxone®)	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
106	Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
107	Glatiramer acetate, n-acetylcysteine	Acetate	2件: D00221, D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
108	Glatiramer acetato	Glatiramer	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
109	Glucocorticoid (prednisone or prednisolone)	Prednisolone	9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 84 💬
110	Gonadorelin	Gonadorelin	4件: D00988, D03267, D04361, D08027 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
111	Gonadorelin acetate and triptorelin acetate	Acetate	5件: D00988, D03267, D04361, D06247, D08027 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
112	Goserelin	Goserelin	2件: D00573, D04405 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件:  1  💬
113	Hematide, peginesatide	Peginesatide	2件: D09946, D09947 💬	1件: EPOR 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	1件: 283 💬
114	High dose dexamethasone pulses	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 63 💬
115	Human interferon beta-1a and glatiramer acetate	Acetate	2件: D04318, D04554 💬	22件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, IFNAR1, IFNAR2 💬	44件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
116	Hydrocortisone acetate	Acetate	2件: D00088, D00165 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
117	Hydrocortisone sodium acetate	Acetate	2件: D00088, D01779 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
118	Hydroxocobalamin	Hydroxocobalamin	3件: D01027, D02707, D04929 💬	-	-	1件: 97 💬
119	Hydroxocobalamin with butyrate	Butyric Acid	4件: D01027, D02707, D04929, D05866 💬	-	-	1件: 97 💬
120	Infliximab, methylprednisolone, methotrexate	Infliximab	9件: D00142, D00407, D00751, D00979, D02115, D02598, D05000, D05001, D05002 💬	4件: DHFR, DHFR2, NR3C1, TNF 💬	70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
121	Interferon-beta-1a (avonex) plus methylprednisolone	Human interferon beta	7件: D00407, D00751, D00979, D04554, D05000, D05001, D05002 💬	3件: IFNAR1, IFNAR2, NR3C1 💬	19件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway	1件: 13 💬
122	Intra-articular compound betamethasone	Betamethasone	7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
123	Intraarticular betamethasone	Betamethasone	7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
124	Intraarticular dexamethasone	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
125	Intravenous (i.v.) methylprednisolone 1000 mg, total 9	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 222 💬
126	Intravenous dexamethasone 1 mg	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
127	Intravenous methyl prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 43 💬
128	Intravenous methylprednisolone	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 13, 145 💬
129	Iv methylprednisolone	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 13 💬
130	Iv methylprednisolone (steroids)	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 13 💬
131	L-lysyl-d-prolyl-l-threonine acetate	Acetate	1件: D00041 💬	-	-	1件: 97 💬
132	L-lysyl-d-prolyl-lthreonine acetate, lyophilisate	Acetate	-	-	-	1件: 97 💬
133	Lanreotide	Lanreotide	1件: D04666 💬	-	-	4件: 67, 73, 85, 298 💬
134	Lanreotide acetate	Acetate	1件: D04666 💬	-	-	4件: 67, 73, 85, 298 💬
135	Lapaquistat acetate and current lipid-lowering treatment	Acetate	-	-	-	1件: 79 💬
136	Lenalidomide and dexamethasone	Dexamethasone	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 16 💬
137	Lenalidomide+dexamethasone	Dexamethasone	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 16 💬
138	Lenalidomide, dexamethasone	Dexamethasone	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 16 💬
139	Lenalidomide, dexamethasone and cyclophosphamide	Cyclophosphamide	12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687, D07760 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 28 💬
140	Leuprolide	Leuprolide	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	5件:  1 ,  2 ,  3 , 51, 76 💬
141	Leuprolide (gnrh agonists)	Gonadorelin	6件: D00988, D00989, D03267, D04361, D08027, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
142	Leuprolide acetate (la)	Acetate	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
143	Leuprolide acetate 11.25 mg	Acetate	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
144	Leuprolide acetate 3 month depot	Acetate	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
145	Leuprolide acetate 30 mg	Acetate	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
146	Leuprolide acetate 45 mg	Acetate	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
147	Leuprolide acetate depot	Acetate	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
148	Leuprorelin acetate	Acetate	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	2件:  1 , 76 💬
149	Leuprorelin acetate 3.75mg injection	Acetate	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
150	Lodotra (delayed release prednisolone)	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 41 💬
151	Loestrin (norethindrone acetate and ethinyl estradiol)	Acetate	11件: D00105, D00182, D00554, D00953, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬	3件: ESR1, ESR2, PGR 💬	11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	1件: 299 💬
152	Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol)	Acetate	11件: D00105, D00182, D00554, D00953, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬	3件: ESR1, ESR2, PGR 💬	11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	2件: 46, 49 💬
153	Long-circulating liposomal prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
154	Low dose prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 84 💬
155	Luphere depot 3.75mg(leuprolide acetate 3.75mg)	Acetate	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
156	Lupron (leuprolide acetate)	Acetate	2件: D00989, D08113 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
157	Macimorelin acetate	Acetate	1件: D10563 💬	1件: GHSR 💬	3件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway	1件: 78 💬
158	Medium dose prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 84 💬
159	Megadose oral methylprednisolone	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 13 💬
160	Megestrol acetate	Acetate	2件: D00952, D08167 💬	1件: PGR 💬	4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation	1件: 76 💬
161	Megestrol acetate tablet	Acetate	2件: D00952, D08167 💬	1件: PGR 💬	4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation	1件: 76 💬
162	Melphalan, thalidomide and dexamethasone	Dexamethasone	11件: D00292, D00369, D00754, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 28 💬
163	Methotrexate + methylprednisolone	Methotrexate	8件: D00142, D00407, D00751, D00979, D02115, D05000, D05001, D05002 💬	3件: DHFR, DHFR2, NR3C1 💬	6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate	1件: 46 💬
164	Methotrexate - etanercept - prednisolone arm	Etanercept	11件: D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬	5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬	70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
165	Methyl prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 43, 49, 96 💬
166	Methylprednisolone	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
167	Methylprednisolone (drug)	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 13 💬
168	Methylprednisolone (mp)	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 60, 285 💬
169	Methylprednisolone (mp) or prednisone (pred)	Methylprednisolone	7件: D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
170	Methylprednisolone (or other glucocorticoid)	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 43 💬
171	Methylprednisolone (solu-medrol)	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 14 💬
172	Methylprednisolone 1250 mg/24h x3 days	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 13 💬
173	Methylprednisolone acetate	Acetate	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 51 💬
174	Methylprednisolone bolus iv 15 mg/kg/d for 3 days.	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 84 💬
175	Methylprednisolone hemisuccinate	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 13 💬
176	Methylprednisolone iv	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 13 💬
177	Methylprednisolone mylan générique	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
178	Methylprednisolone or budesonide	Budesonide	7件: D00246, D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 96 💬
179	Methylprednisolone or prednisolone	Methylprednisolone	14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 65 💬
180	Methylprednisolone po	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 13 💬
181	Methylprednisolone pulse	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 66, 220 💬
182	Methylprednisolone sodium hemisuccinate	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 13, 97 💬
183	Methylprednisolone sodium succinate	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	6件: 13, 46, 49, 50, 51, 211 💬
184	Methylprednisolone(intravenously in the 1st-2nd-3rd month )	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
185	Methylprednisolone(intravenously in the 1st-3rd-5th month)	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
186	Mmf and dexamethasone	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 222 💬
187	Nomegestrol acetate	Acetate	2件: D07222, D08281 💬	1件: PGR 💬	4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation	1件: 13 💬
188	Octreotide	Octreotide	2件: D00442, D06495 💬	1件: SSTR2 💬	4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway	7件: 67, 75, 84, 85, 89, 193, 227 💬
189	Octreotide acetate	Acetate	2件: D00442, D06495 💬	1件: SSTR2 💬	4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway	1件: 227 💬
190	Octreotide lar	Octreotide	2件: D00442, D06495 💬	1件: SSTR2 💬	4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway	2件: 67, 227 💬
191	Octreotide lar / sandostatin lar (lar=long acting release)	Octreotide	2件: D00442, D06495 💬	1件: SSTR2 💬	4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway	1件: 84 💬
192	Octreotide-lar	Octreotide	2件: D00442, D06495 💬	1件: SSTR2 💬	4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway	1件: 67 💬
193	Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone	Mesalazine	7件: D00377, D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
194	Oral methylprednisolone 625 mg/24h x3 days	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 13 💬
195	Oral prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 49, 145 💬
196	Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg	Estradiol	10件: D00105, D00554, D01413, D01617, D01953, D04061, D04063, D04064, D04065, D05209 💬	3件: ESR1, ESR2, PGR 💬	11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	1件: 299 💬
197	Overencapsulated prednisolone tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
198	Paroxetine & prednisolone	Paroxetine	12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬	2件: NR3C1, SLC6A4 💬	3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle	1件: 46 💬
199	Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp	Paroxetine	12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬	2件: NR3C1, SLC6A4 💬	3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle	1件: 46 💬
200	Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp	Paroxetine	12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬	2件: NR3C1, SLC6A4 💬	3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle	1件: 46 💬
201	Peg-liposomal prednisolone sodium phosphate	Phosphate ion	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 13, 97 💬
202	Peginesatide	Peginesatide	2件: D09946, D09947 💬	1件: EPOR 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	1件: 283 💬
203	Peri-neural dexamethasone 1 mg	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
204	Phosphate and betamethasone acetate, 2 ml.	Acetate	7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 235 💬
205	Plovamer acetate	Acetate	-	-	-	1件: 13 💬
206	Plovamer acetate 0.5 milligram (mg)	Acetate	-	-	-	1件: 13 💬
207	Plovamer acetate 10 mg	Acetate	-	-	-	1件: 13 💬
208	Plovamer acetate 20 mg	Acetate	-	-	-	1件: 13 💬
209	Plovamer acetate 3 mg	Acetate	-	-	-	1件: 13 💬
210	Pomalidomide and dexamethasone	Dexamethasone	10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D08976 💬	3件: IL6, NR3C1, TNF 💬	79件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 28 💬
211	Prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
212	Prednisolone & dipyridamole	Dipyridamole	9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	3件: NR3C1, PDE4A, PDE5A 💬	7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 46 💬
213	Prednisolone + mabthera	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 61 💬
214	Prednisolone 1mg tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
215	Prednisolone 2,5 mg tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
216	Prednisolone 20 mg	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
217	Prednisolone 40 mg	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
218	Prednisolone 5 mg	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 46, 51 💬
219	Prednisolone 5 mg jenapharm	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 41 💬
220	Prednisolone 5 mg tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
221	Prednisolone 5mg gastro-resistant tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 51 💬
222	Prednisolone 5mg tablet	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 81 💬
223	Prednisolone acetate	Acetate	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 222 💬
224	Prednisolone and chlorambucil	Chlorambucil	9件: D00266, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 222 💬
225	Prednisolone and mycophenolate mofetil	Mycophenolate mofetil	12件: D00472, D00752, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05094, D05095, D05096 💬	3件: IMPDH1, IMPDH2, NR3C1 💬	4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism	1件: 222 💬
226	Prednisolone and taper	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 51 💬
227	Prednisolone labesfal	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
228	Prednisolone sodium metasulphobenzoate	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
229	Prednisolone sodium phosphate	Phosphate ion	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	2件: 13, 97 💬
230	Prednisolone sodium succinate	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 95 💬
231	Prednisolone tablets b.p. 5mg	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
232	Prednisolone tablets bp	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
233	Prednisolone tablets bp 1 mg	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
234	Prednisolone tablets usp 5 mg	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
235	Prednisolone-dipyridamole	Dipyridamole	9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	3件: NR3C1, PDE4A, PDE5A 💬	7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 46 💬
236	Prednisolone/prednisone	Prednisolone	9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 49 💬
237	Prednisone (and methylprednisolone)	Methylprednisolone	7件: D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 43 💬
238	Prednisone acetate	Acetate	2件: D00473, D08416 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 40, 49, 224 💬
239	Prednisone acetate tablets	Acetate	2件: D00473, D08416 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 224 💬
240	Prednisone or prednisolone	Prednisolone	9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 66 💬
241	Prednisone, methylprednisolone,cyclophosphamides	Methylprednisolone	7件: D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 42, 43, 45 💬
242	Prednisone/prednisolone	Prednisolone	9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 35 💬
243	Procedure: epidural steroid (dexamethasone) injection	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 70 💬
244	Procedure: warm compress prior to injection of glatiramer acetate	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
245	Pyridoxine plus prednisolone	Prednisolone	10件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02179, D03301, D08454 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 145 💬
246	Sodium acetate	Acetate	1件: D01779 💬	-	-	1件: 81 💬
247	Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate	Acetate	-	-	-	1件: 46 💬
248	Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate	Acetate	-	-	-	1件: 46 💬
249	Soluble prednisolone tablets	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 145 💬
250	Sotrastaurin (inn) acetate	Acetate	1件: D09671 💬	4件: PRKCD, PRKCE, PRKCH, PRKCQ 💬	28件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	1件: 97 💬
251	Sulphasalazine + hydroxychloroquine or prednisolone	Hydroxychloroquine	9件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D08050 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
252	Tesamorelin	Tesamorelin	2件: D06655, D09015 💬	1件: GHRHR 💬	2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction	2件: 78, 265 💬
253	Tesamorelin (egrifta)	Tesamorelin	2件: D06655, D09015 💬	1件: GHRHR 💬	2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction	1件: 265 💬
254	Tetracosactide acetate	Acetate	1件: D00284 💬	1件: MC2R 💬	5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway	2件: 83, 145 💬
255	Theophylline	Theophylline	5件: D00371, D01712, D02017, D06103, D06104 💬	19件: ADORA1, ADORA2A, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬	24件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	2件: 236, 299 💬
256	Theophylline er	Theophylline	5件: D00371, D01712, D02017, D06103, D06104 💬	19件: ADORA1, ADORA2A, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬	24件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 236 💬
257	Tocopherol acetate	Acetate	1件: D02332 💬	-	-	1件: 49 💬
258	Tocopheryl acetate	Acetate	-	-	-	1件: 206 💬
259	Trexan+salazopyrin+oxiklorin+prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 46 💬
260	Trexan+salazopyrin+oxiklorin+prednisolone + infliximab	Infliximab	9件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02598, D03301 💬	2件: NR3C1, TNF 💬	66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
261	Triptorelin acetate and gonadorelin acetate	Acetate	5件: D00988, D03267, D04361, D06247, D08027 💬	1件: GNRHR 💬	2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction	1件: 76 💬
262	Ulipristal acetate	Acetate	1件: D09567 💬	1件: PGR 💬	4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation	1件: 10 💬
263	Z102 (prednisolone and dipyridamole).	Dipyridamole	9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	3件: NR3C1, PDE4A, PDE5A 💬	7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 46 💬
264	Zinc acetate	Acetate	1件: D06408 💬	-	-	2件: 171, 299 💬
265	Zinc acetate (20mg/d)	Acetate	1件: D06408 💬	-	-	1件: 299 💬
266	Zinc acetate dihydrate	Acetate	1件: D06408 💬	-	-	1件: 171 💬
267	Zuretinol acetate	Acetate	-	-	-	1件: 90 💬

先頭へ